Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval
August 31, 2017 at 15:58 PM EDT
Novartis AG announced that the FDA has approved its breakthrough gene transfer treatment - CAR-T Therapy Kymriah.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|